Technology-based Company.

Engaged in advancing innovative solutions for large-scale market applications

Company Overview

Protecting Against Biological Threats

Polyrizon is a clinical development biotech company specializing on the development of innovative nasal gels to provide effective preventative treatment to protect against a wide cross section of viruses, including the COVID-19 virus, influenza, allergens, and other toxins. our proprietary Capture and Contain (“C&C”) hydrogel platform is delivered in the form of nasal sprays, and form a thin gel-based protective shield containment barrier in the nasal cavity that prevents viruses, bacteria, allergens, and other toxins to penetrate the nasal epithelial tissue

Facts and Figures


Medigus’ holdings


Months to first
efficiency trial results


Option to increase
holdings to